![The Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Index (ANI) - Medical Professionals - Mayo Clinic The Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Index (ANI) - Medical Professionals - Mayo Clinic](https://www.mayoclinic.org/-/media/kcms/gbs/medical-professionals/images/2022/07/08/15/33/nafld-progression-767x535.jpg)
The Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Index (ANI) - Medical Professionals - Mayo Clinic
![Frontiers | Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment Frontiers | Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment](https://www.frontiersin.org/files/Articles/615978/fmed-08-615978-HTML/image_m/fmed-08-615978-g001.jpg)
Frontiers | Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment
![The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases | Scientific Reports The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-021-93435-x/MediaObjects/41598_2021_93435_Fig2_HTML.png)
The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases | Scientific Reports
![Serum biomarkers and cut-off values for prediction of hepatic steatosis... | Download Scientific Diagram Serum biomarkers and cut-off values for prediction of hepatic steatosis... | Download Scientific Diagram](https://www.researchgate.net/publication/344284944/figure/tbl2/AS:936732681859072@1600345883123/Serum-biomarkers-and-cut-off-values-for-prediction-of-hepatic-steatosis-and-significant.png)
Serum biomarkers and cut-off values for prediction of hepatic steatosis... | Download Scientific Diagram
![Cells | Free Full-Text | Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) Cells | Free Full-Text | Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)](https://pub.mdpi-res.com/cells/cells-08-00845/article_deploy/html/images/cells-08-00845-g003.png?1566927131)
Cells | Free Full-Text | Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
![Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach - The Lancet Gastroenterology & Hepatology Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach - The Lancet Gastroenterology & Hepatology](https://www.thelancet.com/cms/asset/65646d01-322a-4ab3-bde9-4a5f09044e13/gr1.jpg)
Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach - The Lancet Gastroenterology & Hepatology
![Automated Liver Fat Quantification at Nonenhanced Abdominal CT for Population-based Steatosis Assessment | Radiology Automated Liver Fat Quantification at Nonenhanced Abdominal CT for Population-based Steatosis Assessment | Radiology](https://pubs.rsna.org/cms/10.1148/radiol.2019190512/asset/images/medium/radiol.2019190512.va.gif)
Automated Liver Fat Quantification at Nonenhanced Abdominal CT for Population-based Steatosis Assessment | Radiology
![Frontiers | MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis Frontiers | MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis](https://www.frontiersin.org/files/Articles/774079/fmed-08-774079-HTML/image_m/fmed-08-774079-g001.jpg)
Frontiers | MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis
![Laboratory parameter‐based machine learning model for excluding non‐alcoholic fatty liver disease (NAFLD) in the general population - Yip - 2017 - Alimentary Pharmacology & Therapeutics - Wiley Online Library Laboratory parameter‐based machine learning model for excluding non‐alcoholic fatty liver disease (NAFLD) in the general population - Yip - 2017 - Alimentary Pharmacology & Therapeutics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/00f0445f-ff54-4c98-82fb-3a290e567a92/apt14172-fig-0003-m.jpg)
Laboratory parameter‐based machine learning model for excluding non‐alcoholic fatty liver disease (NAFLD) in the general population - Yip - 2017 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
![Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging | Frontline Gastroenterology Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging | Frontline Gastroenterology](https://fg.bmj.com/sites/default/files/highwire/flgastro/5/3.cover-source.jpg)
Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging | Frontline Gastroenterology
![Cells | Free Full-Text | Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) Cells | Free Full-Text | Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)](https://pub.mdpi-res.com/cells/cells-08-00845/article_deploy/html/images/cells-08-00845-g001.png?1566927131)